FDA Inspection 875657 — Carter BloodCare - Arlington

Carter BloodCare - Arlington — FEI 1677509

The FDA completed an inspection of Carter BloodCare - Arlington on April 23, 2014 in Arlington, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 23, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Arlington, TX (United States)